Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues

Journal of Medicinal Chemistry

Volumn 46, Issue 11, 2003, Pages 2125-2131

  Hadjeri, Mohamed ^a   Barbier, Magali ^b   Ronot, Xavier ^b   Mariotte, Anne Marie ^a   Boumendjel, Ahcène ^a   Boutonnat, Jean ^b  

^a UNIV GRENOBLE ALPES   (France)

^b INSTITUT ALBERT BONNIOT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 ETHYLPIPERAZIN 1 YLCARBONYL) 5 HYDROXYCHROMONE; 2 (4 METHYLPIPERAZIN 1 YLCARBONYL) 5 HYDROXYCHROMONE; 2 (N ACETYLPIPERAZIN 1 YLCARBONYL) 5 HYDROXYCHROMONE; 2 (N BENZOYLPIPERAZIN 1 YLCARBONYL) 5 HYDROXYCHROMONE; 2 [N (4 CHLOROBENZYLAMINOCARBONYL)] 5 HYDROXYCHROMONE; 4,6 DIMETHOXYAURONE; 5 HYDROXY 2 (4 BENZYLPIPERAZIN 1 YLCARBONYL)CHROMONE; 5 HYDROXY 2 (4 METHYLPIPERAZIN 1 YLCARBONYL)CHROMONE; 5 HYDROXY 2 (4 PHENYLPIPERAZIN 1 YLCARBONYL)CHROMONE; 5 HYDROXY 2 (MORPHOLIN 1 YLCARBONYL)CHROMONE; 5 HYDROXY 2 (PIPERIDIN 1 YLCARBONYL)CHROMONE; 5,7 DIMETHOXY 3 PHENYL 4 QUINOLONE; AURONE; AZAISOFLAVONE; CHROMONE DERIVATIVE; CYCLOSPORIN A; DAUNORUBICIN; FLAVONE DERIVATIVE; FLAVONOID; GLYCOPROTEIN P; RHODAMINE 123; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL LEVEL; CELL LINE; CELL PROLIFERATION; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR BIOLOGY; MULTIDRUG RESISTANCE; PROTEIN FUNCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CHROMONES; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; FLAVONOIDS; FLUORESCENT DYES; HUMANS; NECROSIS; P-GLYCOPROTEIN; PIPERAZINES; QUINOLINIUM COMPOUNDS; RHODAMINE 123; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0038248843     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm021099i     Document Type: Article

References (37)

1. Bellamy, W. T.; Dalton, W. S.; Dorr, R. T. The clinical relevance of multidrug resistance. Cancer. Invest. 1990, 8, 547.
2. Chen, C.; Chin, J. E.; Ueda, K.; Clark, D. R.; Pastan, I.; Gottesman, M. M.; Roninson, I. B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986, 47, 381-389.
3. Juliano, R. L.; Ling, V.; A surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants. Biochim. Biophys. Acta 1976, 455, 152-162.
4. Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer. Inst. 2000, 92, 1295-1302.
5. Gottesman, M. M.; Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 1993, 62, 385-427.
6. Wiese, M.; Pajeva, I. K. Structure-activity relationships of multidrug resistance reversers. Curr. Med. Chem. 2001, 8, 685-713.
7. Raderer, M.; Scheithauer, W.; Clinical trials of agents that reverse multidrug resistance. Cancer 1993, 72, 3553-3563.
8. Critchfield, J. W.; Welsh, C. J,; Phang, J. M.; Yeh, G. C. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells: activation of P-glycoprotein as a putative mechanism. Biochem. Pharmacol. 1994, 48, 1437-1445.
9. Scambia, G.; Ranellett, F. O.; Benedetti, P.; De Vincenzo, R.; Bonanno, G.; Ferrandina, G.; Piantelli, M.; Bussa, S.; Rumi, C.; Clanfriglia, M.; Manucuso, S. Quercitin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer. Chemother. Pharmacol. 1994, 34, 459-464.
10. Shapiro, A. B.; Ling, V. Effect of quercitin on Hoechest 33342 transport by purified and reconstituted P-glycoprotein. Biochem. Pharmacol. 1994, 34, 459-464.
11. Versantvoort, C. H.; Schuurhuis, G. J.; Pinedo, H. M.; Eekman, C. A.; Kuiper, C. M.; Lankelma, J.; Broxterman, H. J. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumor cells. Br. J. Cancer 1993, 68, 939-946.
12. Boumendjel, A.; Beney, C.; Deka, N.; Mariotte, A. M.; Lawson, M. A.; Trompier, D.; Baubichon-Cortay, H.; A. Di Pietro. 4-Hydroxy-6-methoxyaurones with high-affinity binding to cytosolic domain of P-glycoprotein. Chem. Pharm. Bull. 2002, 50, 854-856.
13. Conseil, G.; Baubichon-Cortay, H.; Dayan, G.; Jault, J.-M.; Barron, D.; Di Pietro, A. Flavonoids: a class of modulators with bifunctional interactions at ATP and steroid-binding sites of the mouse P-glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 9831-9836.
14. Boumendjel, A.; Di Pietro, A.; Dumontet, C.; Barron, D. Recent advances in the discovery of flavonoids and analogues with high- affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. Med. Res. Rev. 2002, 22, 512-529.
15. Comte, G.; Daskiewicz, J.-B.; Bayet, C.; Conseil, G.; Vornery-Vanier, A.; Dumontet, C.; Di Pietro, A.; Barron, D. C-isoprenylation of flavonoids enhances affinity toward P-glycoprotein and modulation of cancer cell chemoresistance. J. Med. Chem. 2001, 44, 763-768.
16. Ecker, G.; Huber, M.; Schmid, D.; Chiba, P. The importance of a nitrogen atom in modulators of multidrug resistance. Mol. Pharmacol. 1999, 56, 791-796.
17. Hiessbock, R.; Wolf, C.; Richter, E.; Hitzler, M.; Chiba, P.; Kratzel, M.; Ecker, G. Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines. J. Med. Chem. 1999, 42, 1921-1926.
18. Chiba, P.; Holzer, W.; Landau, M.; Bechmann, G.; Lorenz, K.; Plagens, B.; Hitzler, M.; Richter, E.; Ecker, G. Substituted 4-acylpyrazoles and 4-acylpyrazolones: synthesis and multidrug resistance-modulating activity. J. Med. Chem. 1998, 41, 4001- 4011.
19. Ferté, J.; Kühnel, J.-M.; Chapuis, G.; Rolland, Y.; Lewin, G.; Schwaller, M. A. Flavonoid-related modulators of multidrug resistance: synthesis, pharmacological activity, and structure-activity relationships. J. Med. Chem. 1999, 42, 478-489.
20. Traxler, P.; Green, J.; Mett, H.; Séquin, U.; Furet, P. Use of a pharmacohphore model for the design of EGFR tyrosine kinase inhibitors: Isoflavones and 3-phenyl-4(1H)-quinolones. J. Med. Chem. 1999, 42, 1018-1026.
21. Beney, C.; Mariotte, A.-M.; Boumendjel, A. An efficient synthesis of 4,6-dimethoxyaurones. Heterocycles 2001, 55, 967-972.
22. Bantick, J. R.; Cairns, H.; Chambers, A.; Hazard, R.; King, J.; Lee, T. B.; Minshull, R. Benzodipyridan derivatives with anti-allergic activity. J. Med. Chem. 1976, 19, 817-820.
23. Lau, C. K.; Belanger, P. C.; Dufresne, C.; Scheigetz, J. Novel cyclization of S-(o-acetylaryl) dimethylthiocarbamates. A new synthesis of 3-hydroxybenzothiophenes and 2-hydroxythio- chromones. J. Org. Chem. 1987, 52, 1670-1673.
24. Ellis, G. P.; Shaw, D. Synthesis and antiallergic activity of some 2-(5-tetrazoyl)chromones. J. Med. Chem. 1972, 15, 865-867.
25. Huke, J. P.; Hillier, I. H.; Infield, R. M.; Suschitzky, J. L. Comments on the electronic structure and reactivity of chromones. J. Chem. Soc., Perkin Trans. 2 1984, 12, 2119-2120.
26. Wang, T.; Zhang, Z.; Meanwell, N. A. Benzoylation of dianions: preparation of monobenzoylated derivatives of symmetrical secondary diamines. J. Org. Chem. 1999, 64, 7661-7662.
27. Canitrot, Y.; Lautier, D. Utilisation de la Rhodamine 123 pour la détection de la résistance pléiotropique. Bull. Cancer 1995, 82, 687-697.
28. Huet, S.; Marie, J. P.; Gualde, N.; Robert, J. Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French drug Resistance Network. Cytometry 1998, 15, 248-256.
29. Essodaïgui, M.; Broxterman, H. J.; Garnier-Suillerot, A. Kinetic analysis of calcein and calcein-acetoxymethylester efflux modiated by the multidrug resistance protein and P-glycoprotein. Biochemistry 1998, 37, 2243-2250.
30. Versantvoort, C. H.; Bagrij, T.; Wright, K. A.; Twentyman, P. R. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int. J. Cancer 1995, 63, 855-862.
31. Boutonnat, J.; Barbier, M.; Muirhead, K.; Mousseau, M.; Grunwald, D.; Ronot, X.; Seigneurin, D. Response of chemosensitive and chemoresistant leukemic cell lines to drug therapy: Simultaneous assessment of proliferation, apoptosis, and necrosis. Cytometry 1999, 42, 1-11.
32. Boutonnat, J.; Muirhead, K.; Barbier, M.; Mousseau, M.; Ronot, X.; Seigneurin, D. PKH26 probe in the study of the proliferation of chemoresistant leukemic sublines. Anticancer Res. 1998, 18, 4243-4252.
33. Doornbos, R.; De Grooth, B.; Kraan, Y.; Van der Poel, C.; Greve, J. Visible diode lasers can be used for flow cytometric immunofluorescence and DNA analysis. Cytometry 1994, 15, 267-271.
34. Hirons, G. T.; Fawcett, J. J.; Crissman, H. A. TOTO and YOYO: New very bright fluorochromes for DNA content analyses by flow cytometry. Cytometry 1994, 15, 129-140.
35. The biological data (tables and figures) regarding the effect on cell proliferation and necrosis (cell cycle, cell division, apoptosis and necrosis) are provided as Supporting Information.
36. Phytochemical Dictionary. In A Handbook of Bioactive Compounds from Plants, 2nd ed.; Harborne, J. B., Baxter, H., Moss, G. P., Eds.; Taylor & Francis Ltd.: London, 1999; pp 363-373.
37. Gaviraghi, G.; Pifferi, G. Chrom-4-one-2-carboxylic acids. German Patent DE 2718041, 1977.